Ask AI
H.Res. 928

Affirming support for most-favored-Nation drug pricing for United States patients.

A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.

Referred to the House Committee on Energy and Commerce.

Rep. Dingell, Debbie [D-MI-6](D-MI)Sponsor
1 cosponsor1 R
1cosponsors1committees3actions
  • Introduced in HouseDec 4, 2025
  1. IntroReferralH11100

    Referred to the House Committee on Energy and Commerce.

  2. IntroReferralH11100

    Submitted in House

  3. IntroReferral1025

    Submitted in House

Affirming support for most-favored-Nation drug pricing for United States patients. — Informed